Pt. Actavis Indonesia is a finished-dose manufacturer based in Indonesia. It appears in 17 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), NPRA (MY) and RCETH (BY). Its GMP standing is certified by BPOM (ID), EAEU_EEC and EMA. Customs aggregates show $552K of exports covering 23 molecules to 6 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Jakarta, Indonesia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DAV (Vietnam) | 14 | None |
| NPRA (MY) | 2 | None |
| RCETH (BY) | 1 | None |
| BPOM (ID) | None | 16 |
| EAEU_EEC | None | 1 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $552K | 6 |
| 2024 | Not reported | $2.0M | 6 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Pt. Actavis Indonesia comes back tiered against every other supplier able to file there.
Start for free